EAF223: Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out how different imaging techniques can help with the evaluation of glioblastoma.
What is the Condition Being Studied?
Brain Cancer
Who Can Participate in the Study?
Adults ages 18+ who:
- Have newly diagnosed glioblastoma (IDH wild type)
- Are planning to receive standard-of-care treatment
- Will have diagnostic surgery within 7 weeks before joining the study
- Are not allergic to imaging agents
For more information about this study, please call 919-684-5301.
Age Group
Adults
What is Involved?
If you chose to join, you will have at least two study MRI scans.
Study Details
Full Title
EAF223: Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)
Principal Investigator
Neuro-oncologist
Protocol Number
IRB:
PRO00115772
NCT:
NCT06319027
Phase
Phase
II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment